Amrubicin

This classification denotes an anthracycline antibiotic with the molecular formula C25H25NO9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 93N13LB4Z2, chemically known as ( -)-(7s,9s)-9-acetyl-9-amino-7-((2-deoxy-beta-d-erythro-pentopyranosyl)oxy)-7,8,9,10-tetrahydro-6,11-dihydroxy-5,12-naphthacenedione but generally known as amrubicin, which bears US NIH Compound Identifier 178149. Amrubicin most often comes in base and hydrochloride forms. European Medicines Agency schedules Amrubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05494MIG. The term AMRUBICIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules amrubicin in its Anatomical Therapeutic Chemical (ATC) Classification. AMRUBICIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amrubicin under HS 29419000 and SITC 54139. As of Q4 2014, AMRUBICIN remains the US FDA Preferred Term for this commodity. Amrubicin bears US NLM identifiers UMLS ID CL405282 and NCI Concept Code C80089. SMILES: O(C1CC(N)(CC2C1C(O)C1C(C2O)C(=O)C2C(C1=O)CCCC2)C(=O)C)C1OCC(O)C(O)C1.